Advertisement

U.S. Markets closed

S&P Futures
5,908.75
+2.75(+0.05%)
Dow Futures
43,548.00
+30.00(+0.07%)
Nasdaq Futures
20,490.25
+6.75(+0.03%)
Russell 2000 Futures
2,294.60
+3.40(+0.15%)
Crude Oil
69.51
+0.29(+0.42%)
Gold
2,745.80
+15.80(+0.58%)

Innate Pharma S.A. (IPH.PA)

Paris - Paris Delayed Price. Currency in EUR

1.8700

-0.0240

(-1.27%)

At close: 05:35PM CEST

Loading interactive chart...

Business Wire
Innate Pharma Appoints Jonathan Dickinson as New Chief Executive Officer and Chairman of the Executive Board
MARSEILLE, France, October 14, 2024--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that its supervisory Board has appointed Jonathan Dickinson as the Company’s new Chief Executive Officer (CEO) and Chairman of the Executive Board, effective November 1, 2024. Jonathan Dickinson succeeds Hervé Brailly, co-founder of the Company, who was interim CEO, during the search process.
Business Wire
Innate Pharma to Host KOL Scientific Symposium on Immunotherapy in New York on October 3, 2024
MARSEILLE, France, September 30, 2024--Innate Pharma to host KOL scientific symposium on immunotherapy in New York on October 3, 2024